2024-02-16 14:41:23 ET
Summary
- Health Catalyst, Inc. went public in 2019 but has experienced dropping revenue growth and worsening operating losses.
- The healthcare analytics market is expected to reach $164.6 billion by 2030, but Health Catalyst faces competition from larger players.
- The company's financial performance has been disappointing, with dropping revenue growth and deteriorating operating margin.
- I think investment dollars would be better invested elsewhere.
Investment Outlook
Health Catalyst, Inc. ( HCAT ) went public in mid-2019, selling its shares at $26.00 each....
Read the full article on Seeking Alpha
For further details see:
Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)